Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:FCX
NYSE:FCXMetals and Mining

Is Freeport-McMoRan (FCX) Pricing Make Sense After Strong Multi‑Year Share Gains

If you are looking at Freeport-McMoRan and wondering whether the current price really reflects its value, this article will walk through what the numbers are actually saying. The stock last closed at US$60.67, with total returns of 0.7% over 7 days, 7.3% over 30 days, 16.8% year to date, 60.9% over 1 year, 49.3% over 3 years and 108.1% over 5 years. This helps frame the context for any valuation work you do today. Recent news around Freeport-McMoRan has kept attention on the stock, as...
TSX:NFI
TSX:NFIMachinery

NFI Group (TSX:NFI) Is Up 5.8% After Securing Major US Transit Bus Orders - What's Changed

NFI Group’s subsidiary New Flyer of America recently confirmed fresh orders from NJ TRANSIT for 375 Xcelsior 40-foot clean-diesel buses, completing a 550-bus base contract, while the Regional Transportation Commission of Southern Nevada exercised options for 50 Xcelsior CNG buses worth about US$56,000,000. Together, these awards highlight NFI’s role as a core supplier to large U.S. transit systems and underscore continuing demand for its bus platforms and related services. We’ll now explore...
NasdaqGM:SMMT
NasdaqGM:SMMTBiotechs

Summit Therapeutics Enters FDA Review As Ivonescimab Trials Broaden Potential

Summit Therapeutics (NasdaqGM:SMMT) had its Biologics License Application for ivonescimab, in combination with chemotherapy, accepted by the US FDA for EGFR mutated advanced non squamous non small cell lung cancer after TKI therapy. The company is running several late stage clinical trials, and recent international Phase III results support expanding ivonescimab development beyond lung cancer. Ivonescimab is also being studied in colorectal cancer, reflecting broader pipeline ambitions...
NasdaqGS:EXPE
NasdaqGS:EXPEHospitality

Is Expedia (EXPE) Quietly Redefining Its Moat With Tiqets And Affirm’s BNPL Integration?

Earlier this week, Expedia Group reported a strong third-quarter earnings beat with record revenue, robust B2B growth and revealed plans to acquire activities platform Tiqets, while also expanding its relationship with Affirm as the exclusive Buy Now, Pay Later provider across key US brands such as Expedia, Hotels.com and Vrbo. Together, the Tiqets acquisition and Affirm partnership highlight Expedia’s push to broaden its full-trip offerings and introduce more flexible payment options across...
TSX:BITF
TSX:BITFSoftware

Bitfarms Pivot To Keel Infrastructure Puts AI Ambitions In Focus

Bitfarms, TSX:BITF, has announced plans to rebrand as Keel Infrastructure. The company intends to redomicile to the United States. Bitfarms plans to shift its primary business focus from bitcoin mining to artificial intelligence and high performance computing infrastructure. For investors watching TSX:BITF, this announcement comes with the share price at CA$2.92. The stock has seen a 43.8% return over the past year, alongside a 141.3% return over the past three years, while the five year...
TSE:2897
TSE:2897Food

A Look At Nissin Foods Holdings (TSE:2897) Valuation After Mixed Nine Month 2025 Results

Nissin Foods Holdings Ltd (TSE:2897) recently released earnings for the nine months to December 31, 2025, reporting sales of ¥586,555 million, net income of ¥39,034 million, and lower basic and diluted EPS compared with a year earlier. See our latest analysis for Nissin Foods HoldingsLtd. The latest earnings update has arrived alongside stronger price action, with a 1 day share price return of 2.13% and a 30 day share price return of 13.64% pushing Nissin Foods HoldingsLtd to ¥3,266. Recent...
NasdaqGS:RDWR
NasdaqGS:RDWRSoftware

Assessing Radware (RDWR) Valuation After New Agentic AI Protection Security Launch

Why Radware’s new AI security launch matters for shareholders Radware (RDWR) has pushed further into AI security with its Agentic AI Protection Solution, a product aimed at tackling risks tied to AI agents, prompt attacks, tool abuse, and sensitive data exposure. The launch builds on Radware’s work around threats like the recently identified ZombieAgent vulnerability and follows the earlier LLM Firewall release. Together, these developments give investors fresh context for thinking about how...
NYSE:NYT
NYSE:NYTMedia

New York Times Digital Growth And Dividend Shift Shape Valuation Story

The New York Times (NYSE:NYT) reported quarterly and annual revenue that came in ahead of prior expectations, driven by digital subscriptions and advertising. The company highlighted strong contribution from its digital products, including news, games, and other subscription offerings. Management announced a higher quarterly dividend, indicating an updated capital return approach for shareholders. The publisher also outlined increased investment in video journalism and new digital content...